Copyright © 2005, European Society of Cardiology
Oxidized LDL, a critical factor in atherogenesis
Department of Medicine, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, AR, United States
* Corresponding author. Department of Internal Medicine, University of Arkansas for Medical Sciences, 4301 W Markham, Slot 532, Little Rock, AR 72205, United States. Tel.: +1 501 686 6724. Email address: lidayuan@uams.edu
Received 2 September 2005; accepted 20 September 2005
| The first 10% of the full text of this article appears below. |
See also article by Zhu et al. [3] (pages 425–432) in this issue.
There is a great deal of experimental, epidemiological, and clinical evidence suggesting that disorders of lipid metabolism play an important role in the pathogenesis of atherosclerosis. To date, there have been many studies investigating the mechanisms by which high levels of LDL-cholesterol affect biology of vessels and cause atherosclerotic lesion formation [1,2]. It has become abundantly clear over the last decade that the oxidatively modified form of LDL (ox-LDL) is more important than native LDL in atherogenesis.
The study in this
| Oxidized LDL and endothelial dysfunction/injury |
|---|
| Oxidized LDL and its receptor LOX-1 in endothelium |
|---|
| Ox-LDL and atherosclerosis |
|---|
This article has been cited by other articles:
![]() |
P. Martinez-Miguel, V. Raoch, C. Zaragoza, J. M. Valdivielso, M. Rodriguez-Puyol, D. Rodriguez-Puyol, and S. Lopez-Ongil Endothelin-converting enzyme-1 increases in atherosclerotic mice: potential role of oxidized low density lipoproteins J. Lipid Res., March 1, 2009; 50(3): 364 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Qahwash, A. Boire, J. Lanning, T. Krausz, P. Pytel, and S. C. Meredith Site-specific Effects of Peptide Lipidation on -Amyloid Aggregation and Cytotoxicity J. Biol. Chem., December 21, 2007; 282(51): 36987 - 36997. [Abstract] [Full Text] [PDF] |
||||

